WA-KYMETA
17.5.2023 07:01:29 CEST | Business Wire | Press release
Kymeta (www.kymetacorp.com), a world leading flat panel satellite antenna company, today announced at CABSAT 2023 that telecom service provider Azyan Telecom (azyansat.om) signed a significant order for its Hawk™ u8 terminals connected by OneWeb, bringing Kymeta and OneWeb’s one-of-a kind LEO (Low Earth Orbit) offering to Oman for the first time. The deal will enable expansion of national telecom capabilities in the region, expediting efforts to implement ubiquitous high-speed, low-latency communications capabilities across the Sultanate.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230516006010/en/
Ahmed Saber, Chief Operating Officer, Azyan Telecom and Thomas Thorne, Regional Vice President, Europe & Middle East, Kymeta. (Photo: Business Wire)
Uniquely enabled by a software-first approach, Kymeta’s electronically steered flat panel Hawk u8 will help deliver reliable, truly mobile broadband connectivity across sectors in Oman connected via OneWeb’s LEO satellite constellation, including in areas where challenging terrain and frequent hurricanes often hinder high-speed connectivity offerings. The deal follows closely on the heels of Kymeta’s announcement that the Hawk u8 is now commercially available worldwide.
“As access to mobile broadband becomes increasingly imperative for progress across every major industry, Kymeta has doubled down on our commitment to deliver truly mobile connectivity to customers around the world,” said Walter Berger, President and Co-CEO, Kymeta. “We are invigorated by the opportunity to deliver our solutions to the Sultanate of Oman alongside Azyan Telecom, which we see as an emblematic step forward as we continue to expand our partnerships in the region.”
Ahmed Saber, Chief Operation Officer, Azyan Telecom added, “Today marks an exciting milestone, both for the growth of Oman’s LEO market and our efforts to enhance high-speed satellite connectivity for companies and communities across the region. Our deal with Kymeta will allow us to deliver on the widespread demand for reliable connectivity, in line with Oman's digital transformation strategy. We are thrilled at the opportunity to expand upon our offerings in support of industries across Oman and grateful for the continued support of the Telecommunication Regulatory Authority.”
Widely adopted by military, government, and enterprise customers, Kymeta offers the world’s only high-bandwidth, low-power, fully integrated family of high throughput mobile terminals. With the Hawk u8 LEO terminal, Kymeta customers can access OneWeb’s high-speed, low-latency broadband connectivity services while on the move or stationary as these services continues to be rolled out across the world.
The terminals will be available for delivery to the Omani market in Q1, 2024. For more information, direct inquiries to Kymeta and Azyan Telecom’s contacts, listed below.
About Kymeta
Kymeta is the industry leader in flat panel satellite antennas, providing purpose-built solutions across a variety of enterprise and military applications and unlocking the commercial value of space to address the vast, unmet demand for ubiquitous broadband and truly mobile connectivity for customers around the world. Its innovative metasurface technology, coupled with a software-first approach, delivers the first commercially available, metamaterial-based and electronically steered flat panel satellite antenna. Kymeta’s low-cost, low-power and high throughput solutions make it easy to connect on the move or while stationary – for any vehicle, vessel, aircraft, or fixed platform – enabling industries on earth to transform their operations by harnessing capacity in space.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com.
About Azyan Telecom
Azyan Telecom, a fully owned Omani entity, is the first licensed VSAT service provider with expertise in VSAT connectivity, network consultancy and support in the Sultanate of Oman with its earth station being in Muscat, Oman. Azyan Telecom has a very strong satellite footprint in Oman and can provide VSAT Connectivity to the entire country including remote and rural areas. Azyan Telecom delivers reliable, near real-time, mission-critical communications services and creates the vital lines of communication that help improve lives, build businesses, and develop new opportunities.
Azyan Telecom is a leading provider of business-critical Telecommunication and managed services in the Sultanate of Oman. As one of the top satellite companies in the region Azyan Telecom provides High Quality communication with reliable Satellite Services. Find out more at http://www.azyansat.om.
About OneWeb:
OneWeb is a global communications network powered from space, enabling connectivity for governments, businesses, and communities. It is implementing a constellation of low Earth orbit (LEO) satellites with a network of global gateway stations and a range of user terminals to provide an affordable, fast, high-bandwidth and low-latency communications service, connected to the IoT future and a pathway to 5G.
Find out more at http://www.oneweb.world.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230516006010/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom